Titlebook: Melanoma; Biologically Targete Ernest C. Borden (Director) Book 2002 Springer Science+Business Media New York 2002 Staging.angiogenesis.met

aggression

書目名稱Melanoma影響因子(影響力)




書目名稱Melanoma影響因子(影響力)學(xué)科排名




書目名稱Melanoma網(wǎng)絡(luò)公開度




書目名稱Melanoma網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Melanoma被引頻次




書目名稱Melanoma被引頻次學(xué)科排名




書目名稱Melanoma年度引用




書目名稱Melanoma年度引用學(xué)科排名




書目名稱Melanoma讀者反饋




書目名稱Melanoma讀者反饋學(xué)科排名

chlorosis

A Pathologist’s Perspective on Prognostic Features of Malignant Melanomaw of pigment lesion pathology. It consists of benign nevus, including dysplastic nevus, . melanoma, and invasive melanoma. These are regarded as discrete entities with only minimal reference to a sequence of change from dysplasia to melanoma. Once invasive melanoma is diagnosed, the only additional

Cardioversion

Charade

caldron

Immunotherapy of Advanced Melanoma Directed at Specific Antigens with melanoma. Several lines of evidence may support this hypothesis: (.) in documented cases of children with spontaneous regression of cancer, melanoma has been found to be the cancer second in incidence to neuroblastoma .; (.) approximately 5% of patients with metastatic melanoma have an unknown

Adenocarcinoma

Melanoma Antigensost simple approach seemed to be to inject subjects with crude tumor material, and there have been well over a hundred reports from 1902 through 1990 of patients being injected with tumor extracts . .Few of these reports are interpretable, however. Early studies in the 1950s using inbred strains of

施舍

chondromalacia

Interleukin-12uration factor .,.. It was identified as a factor secreted by Epstein Barr virus-transformed B cell lines. Its production can be induced by bacteria, intracellular parasites, viruses, or their products in T cell-dependent and -independent pathways. IL-12 has proinflammatory and immunoregulatory acti

aqueduct

Interferonsntial role of biological strategies for melanoma. IFN-α2 is now licensed in more than 50 countries for more than a dozen clinical indications including melanoma. The clinical effectiveness of IFN-α2 has been established both in the adjuvant and metastatic clinical settings. IFNs were the first previ

Cleave